CVS Health Corp vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? CVS Health Corp trades at $106.51 (market cap $135.48B), while Direxion Daily Semiconductor Bull 3X Shares trades at $160.85. The key difference: CVS Health Corp pays a 2.51% dividend while Direxion Daily Semiconductor Bull 3X Shares pays none, and CVS Health Corp is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| CVS | SOXL | |
|---|---|---|
Market Cap | $135.48B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $106.18 | $300.77 |
52-Week Low | $58.75 | $23.99 |
Enterprise Value | $202.02B | — |
Dividend Yield | 2.51% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
SOXL, a 3x leveraged semiconductor ETF, trades at $165.37, down 13.99% in 24 hours amid sector-wide volatility. Technical indicators show a bearish trend with support at $159 and resistance at $168. Recent news highlights sharp declines driven by SK Hynix's expansion and AI stock sell-offs, exposing the fund's sensitivity to leverage decay and chip sector swings.
The outlook remains high-risk due to leveraged structure and semiconductor cyclicality. Near-term pressure from oversupply concerns and hedge fund selling suggests caution, though dips may attract speculative buys. Key risks include volatility decay and broader tech sentiment shifts.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →